Obvius Investment B.V., as subsidiary of Obvius Pharmaceuticals B.V. is MAH for Europe of Carmustine Obvius 100 MG.
Obvius Pharmaceuticals offers a complete product solution to pharmaceutical companies covering European and Middle Eastern countries. All services are built on an intimate knowledge of the pharmaceutical market. Obvius Pharma has three main points of interest: licensed medicines as well as global sourcing and...
Obvius Investment B.V., as subsidiary of Obvius Pharmaceuticals B.V. is MAH for Europe of Carmustine Obvius 100 MG.
Obvius Pharmaceuticals offers a complete product solution to pharmaceutical companies covering European and Middle Eastern countries. All services are built on an intimate knowledge of the pharmaceutical market. Obvius Pharma has three main points of interest: licensed medicines as well as global sourcing and advisory services.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.